Literature DB >> 15378218

CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Marc Steinborn1, Steffen Leiz, Klaus Rüdisser, Martin Griebel, Thomas Harder, Helmut Hahn.   

Abstract

BACKGROUND: Central nervous system (CNS) involvement is a common complication in haemolytic uraemic syndrome (HUS). Various imaging findings have been described, mostly as case reports. Although there are a few retrospective studies on larger patient groups there is no report that focuses on MRI.
OBJECTIVE: To analyse the CT and MRI studies of patients with neurological complications of HUS, to describe the typical imaging findings, and to evaluate their predictive character with regard to follow-up examinations and clinical outcome.
MATERIALS AND METHODS: Of 57 patients with clinically proven HUS who were referred to our hospital between 1995 and 2003, 17 had signs of serious CNS involvement and 10 underwent neuroimaging. Nine MRI and seven CT studies were performed in the acute phase and five MRI and two CT studies were done for follow-up.
RESULTS: In six patients, pathological imaging findings were seen on CT or MRI performed in the acute phase of the disease whereas CT and MRI scans were completely normal in four patients. All patients with positive imaging findings had pathological changes within the basal ganglia. Additional findings were seen in the thalami (n=2), cerebellum (n=2) and brain stem (n=1). On follow-up imaging performed in five cases, the pathological imaging findings had resolved completely in two and partially in three patients. All patients had a good neurological outcome. Comparing the various MRI findings, a haemorrhagic component within an acute lesion was the most reliable parameter predicting residual pathologic findings on follow-up imaging.
CONCLUSIONS: Basal ganglia involvement is a typical finding in patients with neurological complications of HUS. Even in patients with severe CNS involvement on acute imaging studies, prognosis was favourable for clinical outcome and resolution of pathological imaging findings.

Entities:  

Mesh:

Year:  2004        PMID: 15378218     DOI: 10.1007/s00247-004-1289-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  23 in total

1.  Localization of verotoxin receptors in nervous system.

Authors:  J Ren; I Utsunomiya; K Taguchi; T Ariga; T Tai; Y Ihara; T Miyatake
Journal:  Brain Res       Date:  1999-04-17       Impact factor: 3.252

Review 2.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

3.  Central nervous system involvement in a child with hemolytic uremic syndrome.

Authors:  E Signorini; S Lucchi; M Mastrangelo; S Rapuzzi; A Edefonti; E Fossali
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

4.  MRI findings of hemolytic uremic syndrome with encephalopathy: widespread symmetrical distribution.

Authors:  Hiroshi Nakamura; Hitonori Takaba; Takeshi Inoue; Yoshisuke Saku; Fumihiko Saito; Setsuro Ibayashi; Masatoshi Fujishima
Journal:  J Neuroimaging       Date:  2003-01       Impact factor: 2.486

Review 5.  Bilateral basal ganglia lesions: pediatric differential considerations.

Authors:  V B Ho; C R Fitz; S H Chuang; C A Geyer
Journal:  Radiographics       Date:  1993-03       Impact factor: 5.333

6.  Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features.

Authors:  A Kelles; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

7.  Lacunar infarction of the basal ganglia as a complication of hemolytic-uremic syndrome. MRI and clinical correlations.

Authors:  F J DiMario; H Brönte-Stewart; J Sherbotie; M E Turner
Journal:  Clin Pediatr (Phila)       Date:  1987-11       Impact factor: 1.168

8.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09

9.  Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy.

Authors:  H Ogura; M Takaoka; M Kishi; M Kimoto; T Shimazu; T Yoshioka; H Sugimoto
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

Review 10.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  31 in total

Review 1.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

2.  Suspicious neuroimaging pattern of thrombotic microangiopathy.

Authors:  T N Ellchuk; L M Shah; R H Hewlett; A G Osborn
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

Review 3.  MR differential diagnosis of acute deep grey matter pathology in paediatric patients.

Authors:  Carlo Cosimo Quattrocchi; Daniela Longo; Luciana Nogueira Delfino; Yuri Errante; Costanza Aiello; Giuseppe Fariello; Bruno Bernardi
Journal:  Pediatr Radiol       Date:  2012-11-30

Review 4.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

Review 5.  Beyond stroke-uncommon causes of diffusion restriction in the basal ganglia.

Authors:  Alok A Bhatt; Justin L Brucker; Jeevak Almast
Journal:  Emerg Radiol       Date:  2017-09-04

6.  Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome.

Authors:  Kathrin Buder; Beatrice Latal; Samuel Nef; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2014-09-19       Impact factor: 3.714

7.  Different classes of antibiotics differentially influence shiga toxin production.

Authors:  Colleen Marie McGannon; Cynthia Ann Fuller; Alison Ann Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

8.  The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome.

Authors:  Dineke Westra; Eiske M Dorresteijn; Auke Beishuizen; Lambert P W J van den Heuvel; Paul P T Brons; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2012-09-23       Impact factor: 3.714

9.  Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4.

Authors:  U Löbel; B Eckert; O Simova; M Meier-Cillien; S Kluge; C Gerloff; J Röther; T Magnus; J Fiehler
Journal:  Clin Neuroradiol       Date:  2013-06-29       Impact factor: 3.649

10.  Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Authors:  Karin Weissenborn; Eva Bültmann; Frank Donnerstag; Anja M Giesemann; Friedrich Götz; Hans Worthmann; Meike Heeren; Jan Kielstein; Anke Schwarz; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.